As CBX3 may act as an upstream regulator of the PI3K/AKT pathway in ccRCC, it is essential to evaluate the mechanisms of action of CBX3 to assess its potential as a drug target. Here, CBX3 is linked to nonpapillary renal cell carcinoma.